🔗 Share this article

A shadow economy for unlicensed weight-loss medications is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Experimental Treatment Gaining Traction Via Social Media

Retatrutide, which is still in clinical trials, is being advertised by online personalities for its supposed weight-reducing properties. Viewers are encouraged to message these accounts directly for source information, while also obtaining promotional offers.

Active Commerce on Social Networks

Separately, a robust market exists on Telegram, where groups with thousands of members share comparison photos, administration instructions and claims of next-day UK delivery. Sellers market the drug there before directing customers to other platforms for transactions.

Learning About Retatrutide

Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Medical Professionals Express Concerns

However, doctors and pharmacists have cautions that the sale of what remains an unapproved drug in the UK is worrisome and could lead to users administering substances of unknown origin.

Some experts stated the demand for the experimental drug could be connected to the rising cost of licensed weight loss products such as Mounjaro.

Legal Position and Enforcement

Selling retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that must not be marketed or distributed for personal consumption under the British medical regulations.

Some content creators attempt to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still violate medicines, marketing, and consumer regulations, risking fines, prosecution or imprisonment.

Service Reaction and Content Removal

Based on TikTok, the service has taken down violative content and prohibited related keywords and query recommendations. The company said it was dedicated to keeping the platform secure and allocating resources in enhancing enforcement strategies.

Online Marketplace Operations

Research also found communities with up to nine thousand participants marketing the experimental drug using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately brings up channels with thousands of members, filled with images of weight loss, positive reviews and step-by-step instructions for preparing or administering at home.

Within minutes of entering one group, a seller posted WhatsApp details, where the majority of purchases take place. The seller sent an guidebook and promised delivery within two days. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one asked about body mass, health issues or past usage.

Item Information and Costs

Inside these communities, messages show black plastic packages with Royal Mail stickers, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with sterile water, or ready-to-use injectors typically priced at £160 for 20mg. When questioned how long a pen should be used, sellers give contradictory answers ranging from a several days to “depends on your body”.

Platform Moderation and Safety Actions

A representative for Telegram said it actively monitored harmful content on its platform including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering materials they cannot confirm. Even if the research behind this drug is sound, these digital versions may not include what they claim,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to recent price rises for approved slimming medications such as Mounjaro. “With prices rising, patients are using social media. But counterfeit injections are highly dangerous. You cannot know what’s inside or whether the conditions they were made in was sterile,” she said.

Her team has previously encountered individuals injured by self-injection from unverified suppliers. “We understand the frustration, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be impure or incorrectly dosed.”

Manufacturer Statement

A representative from Eli Lilly said the substance was in third stage research studies and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this point no one can market [it] for human use,” they said, noting that any item “falsely representing itself as a Lilly investigational substance not yet approved … may subject patients to possibly serious medical dangers”.